Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A6 | Q3KNW5 | 3/20 | 0.67 |
| ▸ | SLC10A2 | Q12908 | 2/20 | 0.67 |
| ▸ | SLC10A1 | Q14973 | 2/20 | 0.67 |
| ▸ | GPR27 | Q9NS67 | 9/20 | 0.61 |
| ▸ | AVPR2 | P30518 | 2/20 | 0.55 |
| ▸ | METAP2 | P50579 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | CRHBP | P24387 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7120319 | 0.88 | SLC10A6 (0.76) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL7213183 | 0.87 | SLC10A6 (0.73) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL14394646 | 0.87 | GPR27 (0.50) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL14113153 | 0.86 | SLC10A6 (0.63) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL7212991 | 0.86 | SLC10A6 (0.73) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL7116008 | 0.82 | SLC10A6 (0.85) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL7213023 | 0.82 | SLC10A6 (0.73) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL6756862 | 0.80 | SLC10A6 (1.00) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL7117455 | 0.80 | SLC10A2 (0.60) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 | |
| SCHEMBL7214441 | 0.80 | GPR27 (0.57) | SLC10A6SLC10A2SLC10A1GPR27AVPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080167347-A1 | Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives | SHIONGI & CO., LTD. (JP) | 2008-07-10 | — | — | US | disclosed |
| US-20080167347-A1 | Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives | SHIONGI & CO., LTD. (JP) | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167347-A1 | Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives | CCNY, HDGF, GLI1 | SLC10A6 210/4885SLC10A2 2312/4885SLC10A1 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.